Brand Name : Diclozor-SP
Packing : 10*10
Composition : Diclofenac Potassium 50mg+Paracetamol 325 mg + Serratiopeptidase 10mg Tablet
Composition : Diclofenac Potassium 50mg+Paracetamol 325 mg + Serratiopeptidase 10mg Tablet
In today’s fast-paced world, the need for effective pain management solutions is more critical than ever. Diclozor-SP, a powerful anti-inflammatory and analgesic formulation by Norchem Healthcare, offers robust relief from pain and swelling caused by musculoskeletal injuries, post-surgical inflammation, and various orthopedic conditions. With its scientifically balanced composition of Diclofenac Potassium, Paracetamol, and Serratiopeptidase, Diclozor-SP is among the top choices for physicians seeking comprehensive pain relief for their patients.
Formulated and marketed by Norchem Healthcare, a fast-growing pharmaceutical company in Himachal Pradesh, Diclozor-SP also presents a lucrative opportunity for pharma professionals seeking a pharma franchise in Himachal Pradesh.
Each tablet of Diclozor-SP contains:
This triple-action formulation offers pain relief (analgesic), anti-inflammatory, and anti-edematous benefits, making it ideal for a wide spectrum of acute and chronic pain conditions.
The combination results in faster, deeper, and longer-lasting relief, distinguishing Diclozor-SP from ordinary painkillers.
Diclozor-SP is widely prescribed in the treatment of:
Its triple-action formula addresses both the symptoms and the underlying inflammation, helping patients recover faster with fewer complications.
While Diclozor-SP is generally well-tolerated, certain precautions should be taken:
Possible side effects may include:
Medical attention should be sought in case of any severe or unusual symptoms.
Physicians across India, especially orthopedic, dental, surgical, and general practitioners, prefer Diclozor-SP due to:
Norchem Healthcare, located in the pharmaceutical hub of Himachal Pradesh, is known for its commitment to quality, affordability, and ethical standards. As a WHO-GMP and ISO-certified company, Norchem ensures that every product, including Diclozor-SP, is manufactured using top-grade raw materials and follows strict quality protocols.
Being a pharmaceutical company in Himachal Pradesh, Norchem benefits from the region’s industrial support, skilled workforce, and pollution-free environment, allowing it to deliver world-class pharmaceutical formulations at competitive prices.
With the increasing demand for pain management drugs and rising healthcare awareness, the pharmaceutical sector in India is flourishing. Norchem Healthcare offers a profitable pharma franchise in Himachal Pradesh, empowering medical distributors, wholesalers, and entrepreneurs to establish their business under a trusted brand.
Diclozor-SP meets the increasing demand for safe, fast, and effective pain relief. Due to:
…it has emerged as a high-demand product in both urban and rural markets.
Franchise holders can expect regular prescriptions, higher brand recall, and strong repeat sales from Diclozor-SP.
Diclozor-SP by Norchem Healthcare is not just a medicine — it’s a therapeutic solution that brings together the best of science, safety, and swift results. Its triple-action formula provides fast, sustained, and comprehensive relief from inflammation and pain.
If you are a healthcare provider, distributor, or aspiring entrepreneur, consider adding Diclozor-SP to your offering and partner with Norchem Healthcare, a leading pharmaceutical company in Himachal Pradesh, for a profitable pharma franchise in Himachal Pradesh.